17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy: Revision history

20 October 2022

• curprev 08:0408:04, 20 October 2022‎ Abdulkerim Yassin talk contribs‎ 2,342 bytes +16‎ →‎Surgical therapy
• curprev 08:0308:03, 20 October 2022‎ Abdulkerim Yassin talk contribs‎ 2,326 bytes +1‎ →‎Surgical therapy
• curprev 07:5907:59, 20 October 2022‎ Abdulkerim Yassin talk contribs‎ 2,325 bytes +8‎ →‎Surgical therapy
• curprev 07:5807:58, 20 October 2022‎ Abdulkerim Yassin talk contribs‎ 2,317 bytes +8‎ →‎Surgical therapy
• curprev 07:5507:55, 20 October 2022‎ Abdulkerim Yassin talk contribs‎ 2,309 bytes +91‎ →‎Surgical therapy
• curprev 07:5407:54, 20 October 2022‎ Jose Loyola talk contribs‎ 2,218 bytes +34‎ No edit summary

13 October 2022

• curprev 10:1410:14, 13 October 2022‎ Jose Loyola talk contribs‎ 2,184 bytes −362‎ No edit summary
• curprev 10:0210:02, 13 October 2022‎ Jose Loyola talk contribs‎ 2,546 bytes +2,546‎ Created page with "__NOTOC__ {{17-beta-hydroxysteroid dehydrogenase deficiency}} {{CMG}}; {{AE}} {{Abdulkerim}} ==Overview== If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discussed, depending on the expected result of virilization genioplasty. ==Medical therapy== *If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discused. Patients with this d..."